Myrto Frangos
Pediatric Endocrinology · Chesterfield, MONPI 1780756403
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Among pediatric endocrinology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$869
- Medtronic$768
- Ascendis Pharma Endocrinology Inc$729
- Novo Nordisk$447
- Sanofi-aventis U.S. LLC$428
- Tandem Diabetes Care, Inc.$426
- plus $3K from 27 others
What the payments were for
- Consulting fees$1903%
- Food & beverage$6,77997%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $869 |
| Medtronic(2 entities) | 9 | $768 |
| Ascendis Pharma Endocrinology Inc | 31 | $729 |
| Novo Nordisk | 24 | $447 |
| Sanofi-aventis U.S. LLC | 7 | $428 |
| Tandem Diabetes Care, Inc. | 22 | $426 |
| Neurocrine Biosciences, Inc. | 13 | $363 |
| Insulet Corporation | 9 | $282 |
| Xeris Pharmaceuticals, Inc. | 12 | $219 |
| Dexcom, Inc. | 6 | $211 |
| Azurity Pharmaceuticals, Inc. | 10 | $203 |
| Tolmar, Inc. | 11 | $197 |
| Arbor Pharmaceuticals, Inc. | 5 | $183 |
| Amphastar Pharmaceuticals, Inc. | 10 | $175 |
| Ferring Pharmaceuticals Inc. | 12 | $166 |
| Endo Pharmaceuticals Inc. | 9 | $157 |
| Lilly USA, LLC | 9 | $146 |
| Sandoz | 7 | $143 |
| Amneal Pharmaceuticals LLC | 10 | $139 |
| Pfizer | 9 | $125 |
| AstraZeneca | 5 | $99 |
| Abbott | 5 | $88 |
| Ipsen Biopharmaceuticals, Inc | 4 | $68 |
| Companion Medical, Inc. | 2 | $64 |
| BETA Bionics, Inc. | 4 | $61 |
| Sequel Med Tech, LLC | 2 | $57 |
| Lifescan, Inc. | 3 | $55 |
| Tolmar Pharmaceuticals, Inc. | 3 | $46 |
| Eton Pharmaceuticals, Inc. | 2 | $41 |
| IBSA Pharma Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$385
- TZIELD$262
- SKYTROFA$248
- Triptodur$125
- Synthroid$125
- CRENESSITY$123
- DEXCOM G6 TRANSMITTER$116
- Omnipod$116
- Minimed 670G System$103
How this compares
$7,012 in reported general payments places this provider in the 90th percentile of 48 pediatric endocrinology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $105 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $139 | $10513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 48 pediatric endocrinology providers in Missouri.
Other pediatric endocrinology in Chesterfield
- Ryan McDonoughKansas City$195K
- Joseph CernichKansas City$25K
- Neil WhiteSaint Louis$15K
- Matthew FeldtKansas City$13K
- Kyle McNerneySaint Louis$5K
- Amy ClarkSaint Louis$4K
- Mahmoud Adeeb Ah HamdanColumbia$3K
- Erica ZarseKansas City$3K
- Katherine HefnerSpringfield$2K
- Michelle KnollKansas City$940
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.